Related Experiment Video

Updated: Feb 18, 2026

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
10:26

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations

Published on: November 7, 2019

6.1K

Ubiquitin levels: the next target against gynecological cancers?

Diane L Haakonsen, Michael Rape

    The Journal of Clinical Investigation
    |November 14, 2017
    PubMed

    Insights

    Researchers found that some gynecological cancers have low levels of the UBB gene, making them vulnerable to drugs targeting the UBC gene. Inhibiting UBC significantly reduced tumors and improved survival in mice, suggesting a new cancer therapy strategy.

    Area of Science:

    • Cellular biology
    • Cancer research
    • Biochemistry

    Background:

    • Ubiquitylation is a critical cellular process for cell survival and function.
    • The ubiquitin pathway is a promising therapeutic target for various cancers.
    • Dysregulation of ubiquitylation is implicated in cancer development.

    Purpose of the Study:

    • To identify novel therapeutic targets in gynecological cancers.
    • To investigate the role of ubiquitin genes UBB and UBC in cancer progression.
    • To explore the potential of targeting the ubiquitin pathway for cancer treatment.

    Main Methods:

    • Analysis of UBB gene expression in gynecological cancer samples.
    • Inhibition of the UBC gene in cancer cells and mouse models.
    • Assessment of tumor burden and survival rates following UBC inhibition.

    Main Results:

    • A subset of gynecological cancers exhibits repressed UBB gene expression.
    • These cancers are sensitive to further reduction in ubiquitin production via UBC inhibition.
    • Inducible depletion of UBC in mice with low UBB levels led to decreased tumor burden and prolonged survival.

    Conclusions:

    • A synthetic lethal relationship exists between UBB and UBC.
    • Targeting UBC offers a potential therapeutic strategy for UBB-deficient gynecological cancers.
    • This finding opens new avenues for developing targeted cancer therapies.

    More Related Videos

    Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

    Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

    Published on: May 10, 2022

    3.2K
    In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

    In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

    Published on: July 25, 2019

    11.5K

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.0K
    Regulated Protein Degradation02:58

    Regulated Protein Degradation

    It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
    Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
    9.0K